And Why So Great a “No?”
Chronic diseases are the dominant issues for global public health in terms of mortality, morbidity, and cost, and they have been identified as such for>40 years. Despite their predominance, however, these diseases —cardiovascular disease (CVD), diabetes, cancer, pulmonary disease, mental health, and dementia—attract little attention in the public health curriculum and even less from the funding community. We explore the rationales that have perpetuated this inability or unwillingness to match need with ef fort. (Source: CVD Prevention and Control)
Source: CVD Prevention and Control - November 30, 2016 Category: Cardiology Authors: Henry Greenberg, Stephen R. Leeder, Susan U. Raymond Tags: Review Source Type: research
Chronic Disease Challenges in the Caribbean
The first summit in the world to address noncommunicable diseases (NCD) was convened by leaders of the Caribbean Community (CARICOM) in 2007. The resulting 15-point Port of Spain (POS) Declaration, “Uniting to stop the epidemic of chronic NCDs,” called for Caribbean governments to take actions and implement policies to prevent and control NCD [1]. (Source: CVD Prevention and Control)
Source: CVD Prevention and Control - November 30, 2016 Category: Cardiology Authors: Trevor Hassell, Anselm Hennis Tags: Viewpoint Source Type: research
Polypill: Can its Potential Enhancement of Efficacy Trigger New Interest?
Heralded as “one of the boldest claims for a new intervention” [1], the concept of the polypill was first introduced in 2003 by Professors Nicholas Wald and Malcolm Law [2]. Conceived as a pill containing 3 blood pressure–lowering drugs from various classes, aspirin, statin, and folic acid, the polypill w as designed for 2 population types: all individuals with established cardiovascular disease (CVD), and because the relative risk for cardiovascular (CV) events increases linearly with age, all individuals without CVD but older than age 55 years. (Source: CVD Prevention and Control)
Source: CVD Prevention and Control - November 30, 2016 Category: Cardiology Authors: Jennifer Chao, Sameer Bansilal Tags: Viewpoint Source Type: research
Confronting Global Chronic Disease
Schools of public health were founded exactly 100 years ago in response to the Rockefeller Commission's Welch-Rose Report, which called for creation of new academic institutions that would be responsible for developing the science and evidence base as to how to keep populations healthy and prevent disease, disability, and injury; educate the futu re leaders and practitioners in the field; and work in partnership with policy and practice sectors to translate the evidence into advances in health for all [1]. (Source: CVD Prevention and Control)
Source: CVD Prevention and Control - November 30, 2016 Category: Cardiology Authors: Linda P. Fried Tags: Viewpoint Source Type: research
New Partnerships to Advance Global Health Research for NCD
Strategic partnerships are crucial for advancing health and health research, especially in the global arena [1 –3]. One form of these partnerships is the public-private partnership (PPP) that brings together researchers from the public and private sectors as well as stakeholders from civil society with complementary skills, resources, and a common mission to advance global health. However, it was not until the 1990s that public-private partnerships (PPP) in global health emerged [4]. Since that time, PPPs have proliferated [3] and so have their functions and goals. (Source: CVD Prevention and Control)
Source: CVD Prevention and Control - November 30, 2016 Category: Cardiology Authors: George A. Mensah Tags: Viewpoint Source Type: research
Little Beacons of Change
Worldwide, there has been a major shift in the most common etiologies of death and disability from infectious etiologies to chronic diseases, with ischemic heart disease and stroke now the leading causes of mortality. These chronic illnesses are significantly related to unhealthy lifestyle choices. Unhealthy habits that develop during childhood have been shown to persist into adulthood [1,2]. The Bogalusa Heart Study demonstrated that 77% of obese children remained obese as adults, and child overweight predicts adult risk factor levels and cardiovascular disease (CVD) morbidity [2]. (Source: CVD Prevention and Control)
Source: CVD Prevention and Control - November 30, 2016 Category: Cardiology Authors: Jacqueline Latina, Sameer Bansilal, Rajesh Vedanthan, Valentin Fuster Tags: Viewpoint Source Type: research
The Global Burden of Disease Study and the Preventable Burden of NCD
Noncommunicable diseases (NCD) now account for more than one-half of the global burden of disease. Cardiovascular diseases account for about one-half of NCD deaths, and the majority of cardiovascular disease deaths occur in low- and middle-income countries. The GBD (Global Burden of Disease) study measures and benchmarks health loss from death or disability from more than 300 diseases in over 100 countries. According to GBD analyses, the rise of NCD is in part due to increased life expectancy due to reduced premature mortality from communicable, child, and maternal illnesses, but preventable risk factors also contribute an...
Source: CVD Prevention and Control - November 30, 2016 Category: Cardiology Authors: Catherine P. Benziger, Gregory A. Roth, Andrew E. Moran Tags: Review Source Type: research
The Fight Against CVD in a Region of the Russian Federation
Cardiovascular diseases (CVD) remain the number 1 problem in the Russian Federation and the Republic of Tatarstan. Tatarstan is a semiautonomous republic within the Russian Federation with a population of 3,803,200 people [1]. It has a mixed agricultural and industrial economy and its per capita income places it in the upper third of the Russian Federation's regions [2]. CVDs are responsible for more than 50% of the total mortality in the Republic of Tatarstan, although the mortality rate has declined in recent years. (Source: CVD Prevention and Control)
Source: CVD Prevention and Control - November 30, 2016 Category: Cardiology Authors: Albert S. Galyavich, Adel Yu. Vafin, Liliya E. Ziganshina Tags: Viewpoint Source Type: research
China's Multisectoral Approach to Chronic Disease
According to the Chinese noncommunicable chronic diseases (NCD) status report released in January of 2016, over 86% of all deaths in 2012 were due to NCD, an estimated 8.4 million deaths in 1 year [1]. China is home to the largest population in the world as well as to the largest number of NCD patients, but the massive size of the patient population and related health, social, and economic burden is not the only problem in NCD that China faces. The rate of increase in population aging and NCD burden has even outpaced the astonishing rate of economic development since 1978 [2]. (Source: CVD Prevention and Control)
Source: CVD Prevention and Control - November 30, 2016 Category: Cardiology Authors: Lijing L. Yan, Lingzhi Kong Tags: Viewpoint Source Type: research
A Chronology of Global Assistance Funding for NCD
Funding from the global community for noncommunicable disease (NCD) prevention and control in developing countries is miniscule —dwarfed by donor support for communicable diseases, maternal and child health, and other traditional health concerns in low-income countries. Yet, NCD now constitute the bulk of illness and deaths in low-income countries with, to date, only a small uptick in donor funding evident as a response. T his paper describes recent magnitude and trends in the development of assistance for NCD; identifies the main sources among the 3 groupings of multilateral, bilateral, and private philanthropic funders...
Source: CVD Prevention and Control - November 30, 2016 Category: Cardiology Authors: Rachel Nugent Tags: Review Source Type: research
Cardiovascular Diseases on the Global Agenda
In 2011, the United Nations (UN) organized the first ever meeting for heads of state to discuss the problem of noncommunicable diseases (NCD), including cardiovascular disease (CVD), cancer, chronic respiratory disease, and diabetes mellitus. Recognizing that these had emerged as leading causes of morbidity and mortality in the world, including in many low- and middle-income countries, advocates from government and civil society had called for increased attention and a UN response. Earlier, NCD including CVD were absent from the global health agenda in part because of their omission from the Millennium Development Goals. (...
Source: CVD Prevention and Control - November 30, 2016 Category: Cardiology Authors: Johanna Ralston, K. Srinath Reddy, Valentin Fuster, Jagat Narula Tags: Review Source Type: research
The Funding for the NCD
The public health assault on global chronic diseases has been nearly nonexistent for the 45 years since Omran's definition of the epidemiological transition [1]. Because of the soft-money infrastructure of most schools of public health coupled with the lack of external funding from philanthropy, the usual donor countries, and international agencies, faculty development and commitment have been squelched. Without a means of supporting a faculty committed to chronic diseases, there is little if any curricular support. (Source: CVD Prevention and Control)
Source: CVD Prevention and Control - November 30, 2016 Category: Cardiology Authors: Henry Greenberg, Jagat Narula Tags: Editor's Page Source Type: research
NCD Research in the Post-2015 Global Health Agenda
Noncommunicable diseases (NCD) caused nearly 40 million deaths worldwide in 2015, representing 71% of global deaths and a 14% increase compared to NCD deaths in 2005 [1]. NCD are also a major contributor to disability and accounted for 18 of the 20 leading causes of age-standardized years lived with disability on a global scale in 2015 [2]. These findings on mortality and disability have tremendous implications for clinical and public health research over the next 15 years, a period covered by the post-2015 United Nations development agenda [3,4]. (Source: CVD Prevention and Control)
Source: CVD Prevention and Control - November 30, 2016 Category: Cardiology Authors: George A. Mensah Tags: Perspectives From NHLBI Source Type: research
---
Jenny NS, Olson NC, Allisony MA, Rifkiny DE, Danielsz LB, de Boerx IH, Wassel CL, Tracy RP (Source: CVD Prevention and Control)
Source: CVD Prevention and Control - November 30, 2016 Category: Cardiology Tags: Correction Source Type: research
Table of Contents
(Source: CVD Prevention and Control)
Source: CVD Prevention and Control - November 30, 2016 Category: Cardiology Source Type: research
